Study on use of vaccines like MMR and PPD in wart
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2019/11/022192
- Lead Sponsor
- SHUNMADHI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.30 patients aged 12-25 years with verruca vulgaris(less than 20 in number) attending the Dermatology OPD during the study period.
2.Patient who has not undergone any prior systemic or topical treatment.
3.Those who are giving consent to participate in the study.
4.Those who are willing for follow up.
1.Prior known allergic response to MMR vaccine
2.Patients who received any other treatments for their warts before enrolment.
3.Patients with H/O asthma,allergic skin disorders, meningitis or convulsions
4. Patient with acute febrile illness or signs of any inflammation or infection.
5.Patients with Hepatitis B & Hepatitis C infection
6. Patients with immunosuppression/ HIV Infection
7.Patients with anogenital warts
8.Patients with H/O TB
9.Induration measuring < 5 mm at 48 hours of Tuberculin skin test and MMR skin test.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method